Barclays’s abrdn Healthcare Investors HQH Stock Holding History

Barclays’s Portfolio HQH Stock Details HQH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,127	Closed	-$641K	–	4394
2021 Q3	$641K	Hold	25,127	–	–	﹤0.01%	3047
2021 Q2	$654K	Buy	25,127 +6,396	+34%	+$158K	﹤0.01%	2915
2021 Q1	$468K	Buy	+18,731	New	+$457K	﹤0.01%	3217

Other funds holding HQH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Barclays's HQH Position: Q4 2021 in Review

Barclays sold out of abrdn Healthcare Investors (HQH) in Q4 2021, closing a stake of 25,127 shares — an estimated $641K sold.

Barclays first reported a position in HQH in Q1 2021 and held it in 3 quarters. The position peaked at $654K in Q2 2021. 105 funds tracked by Wall St. Rank hold HQH as of Q4 2021.

Barclays reported no remaining abrdn Healthcare Investors position as of Q4 2021 after selling out during the quarter.
Barclays sold 25,127 abrdn Healthcare Investors shares in Q4 2021, an estimated $641K.
Barclays first reported a position in abrdn Healthcare Investors in Q1 2021 and held it in 3 quarters.
Barclays's abrdn Healthcare Investors position peaked at $654K in Q2 2021.
105 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.